Effects of lithium on saccadic eye movements in healthy subjects in a ten-day double-blind placebo-controlled cross-over pilot study

被引:3
|
作者
Amado, I [1 ]
Galinowski, A
Daban, C
Ramdane-Cherif, Z
Poirier, E
Bourdel, MC
Poirier, MF
Krebs, MO
机构
[1] Univ Paris Descartes, Hop St Anne, Serv Hospitalouniv, INSERM,E0117,Fac Med Paris Descartes, F-75014 Paris, France
[2] Hop St Anne, Serv Hospitalouniv, Cent Lab, F-75014 Paris, France
关键词
D O I
10.1055/s-2005-916188
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
introduction: Although previous studies have shown that lithium modifies eye movements or psychomotor speed, no studies have ever explored the predictive saccades or memory guided saccades during lithium administration. We took the objective to determine the influence of lithium in pseudo-random, predictive or memory-guided saccades in healthy subjects with a view to detect reduced psychornotor speed, inability to anticipate incoming events, or working memory deficits. Methods: A ten day lithium-placebo randomized double-blind cross-over pilot study was carried out with 12 healthy male volunteers. The cognitive assessment included pseudo-random, predictive and memory guided saccades before and after lithium and placebo periods. A biological assay substantiated the lithium effect on TSH and thyroid hormones. Results: There was no change inpseudo-random or memory guided saccades when comparing lithium or placebo administration. However the ratio of anticipated saccades decreased under the lithium sequence while it remained stable under placebo. Also, subjects having lithium serum levels of > 0.5 meq/l had longer latencies in anticipated saccades. Conclusion: The findings do not support a major effect of lithium on alertness or on working memory, although the dosage and duration of lithium was sufficient to modify TSH blood level. Nevertheless, lithium treatment was associated with decreased anticipation in predictive saccades, suggesting this could reflect a reduced ability to anticipate quick motor movements and could be related to the well-known effect of lithium as an anti-impulsive medication.
引用
收藏
页码:321 / 325
页数:5
相关论文
共 50 条
  • [21] Beneficial effect of Chlorella pyrenoidosa drink on healthy subjects: A randomized, placebo-controlled, double-blind, cross-over clinical trial
    Chiu, Hui-Fang
    Lee, Hsiao-Ju
    Han, Yi-Chun
    Venkatakrishnan, Kamesh
    Golovinskaia, Oksana
    Wang, Chin-Kun
    JOURNAL OF FOOD BIOCHEMISTRY, 2021, 45 (04)
  • [22] Cardiovascular Safety of Prucalopride in Healthy Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trials
    Boyce, Malcolm J.
    Kerstens, Rene
    Beyens, Greet
    Ausma, Jannie
    Vandeplassche, Lieve
    GASTROENTEROLOGY, 2009, 136 (05) : A535 - A535
  • [23] Cardiovascular safety of prucalopride (Resolor®) in healthy subjects:: Results from a randomized, double-blind, placebo-controlled, cross-over trial
    Boyce, Malcolm J.
    Carey, William
    Mannaert, Erik J.
    Mertens, Annemie
    Ausma, Jannie
    GASTROENTEROLOGY, 2008, 134 (04) : A551 - A551
  • [24] A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease
    Lopez-Sendon Moreno, Jose Luis
    Garcia Caldentey, Juan
    Trigo Cubillo, Patricia
    Ruiz Romero, Carolina
    Garcia Ribas, Guillermo
    Alonso Arias, M. A. Alonso
    Jesus Garcia de Yebenes, Maria
    Maria Tolon, Rosa
    Galve-Roperh, Ismael
    Sagredo, Onintza
    Valdeolivas, Sara
    Resel, Eva
    Ortega-Gutierrez, Silvia
    Laura Garcia-Bermejo, Maria
    Fernandez Ruiz, Javier
    Guzman, Manuel
    de Yebenes Prous, Justo Garcia
    JOURNAL OF NEUROLOGY, 2016, 263 (07) : 1390 - 1400
  • [25] The acute effects of oxymetazoline on the nasal airway: A double-blind cross-over placebo-controlled trial in normal subjects.
    Taverner, D
    Bickford, L
    Shakib, S
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R323 - R323
  • [26] Therapeutic Effects of Tamsulosin in Nightmare Disorder: A Randomized, Double Blind, Placebo-Controlled, Cross-Over, Pilot Study
    Naderifar, Negin
    Roohi, Elnaz
    Sharifi, Ali
    Jaafari, Nemat
    Hashemian, Farshad
    DRUG RESEARCH, 2024, 74 (02) : 53 - 59
  • [27] Sinonasal inhalation of dornase alfa in CF: A double-blind placebo-controlled cross-over pilot trial
    Mainz, Jochen G.
    Schiller, Isabella
    Ritschel, Christiane
    Mentzel, Hans-Joachim
    Riethmueller, Joachim
    Koitschev, Assen
    Schneider, Gerlind
    Beck, James F.
    Wiedemann, Baerbel
    AURIS NASUS LARYNX, 2011, 38 (02) : 220 - 227
  • [28] A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease
    Jose Luis López-Sendón Moreno
    Juan García Caldentey
    Patricia Trigo Cubillo
    Carolina Ruiz Romero
    Guillermo García Ribas
    M. A. Alonso Alonso Arias
    María Jesús García de Yébenes
    Rosa María Tolón
    Ismael Galve-Roperh
    Onintza Sagredo
    Sara Valdeolivas
    Eva Resel
    Silvia Ortega-Gutierrez
    María Laura García-Bermejo
    Javier Fernández Ruiz
    Manuel Guzmán
    Justo García de Yébenes Prous
    Journal of Neurology, 2016, 263 : 1390 - 1400
  • [29] Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study
    Andreas W. Schoenenberger
    Renate Schoenenberger-Berzins
    Christoph Auf der Maur
    Paolo M. Suter
    Athanasios Vergopoulos
    Paul Erne
    Clinical Research in Cardiology, 2012, 101 : 159 - 164
  • [30] Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study
    Schoenenberger, Andreas W.
    Schoenenberger-Berzins, Renate
    Maur, Christoph Auf Der
    Suter, Paolo M.
    Vergopoulos, Athanasios
    Erne, Paul
    CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (03) : 159 - 164